Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1049558

1.

FGFR-mediated reactivation of ERK signaling promotes head and neck squamous cancer cell insensitivity to MEK inhibition.

Ban MJ, Byeon HK, Yang YJ, An S, Kim JW, Kim JH, Kim DH, Yang J, Kee H, Koh YW.

Cancer Sci. 2018 Oct 21. doi: 10.1111/cas.13839. [Epub ahead of print]

2.

Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: Multicenter study from an endemic area in Southern China.

Tham T.

Cancer. 2018 Oct 21. doi: 10.1002/cncr.31819. [Epub ahead of print] No abstract available.

PMID:
30343533
3.

Combination immunotherapy with IL-2 surface-modified tumor cell vaccine and PD-1 blockade against renal cell carcinoma.

Zhang X, Shi X, Li J, Hu Z, Gao J, Wu S, Long Z.

Cancer Sci. 2018 Oct 21. doi: 10.1111/cas.13842. [Epub ahead of print]

4.

Pancreatic endocrine-like cells differentiated from human umbilical cords Wharton's jelly mesenchymal stem cells using small molecules.

Belame Shivakumar S, Bharti D, Baregundi Subbarao R, Park JM, Son YB, Ullah I, Choe YH, Lee HJ, Park BW, Lee SL, Rho GJ.

J Cell Physiol. 2018 Oct 21. doi: 10.1002/jcp.27184. [Epub ahead of print]

PMID:
30343506
5.

Reply to Human papillomavirus and World Health Organization type III nasopharyngeal carcinoma: multicenter study from an endemic area in Southern China.

Chan JYW, Huang WB, Liu DL.

Cancer. 2018 Oct 21. doi: 10.1002/cncr.31815. [Epub ahead of print] No abstract available.

PMID:
30343502
6.

Initial experience with dual-energy computed tomography-guided bone biopsies of bone lesions that are occult on monoenergetic CT.

Burke MC, Garg A, Youngner JM, Deshmukh SD, Omar IM.

Skeletal Radiol. 2018 Oct 20. doi: 10.1007/s00256-018-3087-1. [Epub ahead of print]

PMID:
30343440
7.

Purinoceptor expression in hepatocellular virus (HCV)-induced and non-HCV hepatocellular carcinoma: an insight into the proviral role of the P2X4 receptor.

Khalid M, Manzoor S, Ahmad H, Asif A, Bangash TA, Latif A, Jaleel S.

Mol Biol Rep. 2018 Oct 20. doi: 10.1007/s11033-018-4432-0. [Epub ahead of print]

PMID:
30343397
8.

Contribution of the plasma and lymph Degradome and Peptidome to the MHC Ligandome.

Santambrogio L, Rammensee HG.

Immunogenetics. 2018 Oct 20. doi: 10.1007/s00251-018-1093-z. [Epub ahead of print] Review.

PMID:
30343358
9.

Molecular pathways of nonalcoholic fatty liver disease development and progression.

Bessone F, Razori MV, Roma MG.

Cell Mol Life Sci. 2018 Oct 20. doi: 10.1007/s00018-018-2947-0. [Epub ahead of print] Review.

PMID:
30343320
10.

Adherent Perinephric Fat in Asian Patients: Predictors and Impact on Perioperative Outcomes of Partial Nephrectomy.

Kawamura N, Saito K, Inoue M, Ito M, Kijima T, Yoshida S, Yokoyama M, Ishioka J, Matsuoka Y, Kihara K, Fujii Y.

Urol Int. 2018 Oct 18:1-6. doi: 10.1159/000494068. [Epub ahead of print]

PMID:
30343303
11.

Tumor Susceptibility Gene 101 Mediates Anoikis Resistance of Metastatic Thyroid Cancer Cells.

Saharat K, Lirdprapamongkol K, Chokchaichamnankit D, Srisomsap C, Svasti J, Paricharttanakul NM.

Cancer Genomics Proteomics. 2018 Nov-Dec;15(6):473-483. doi: 10.21873/cgp.20106.

PMID:
30343281
12.

Role of BMP-9 in human liver disease.

John M, Kim KJ, Bae SDW, Qiao L, George J.

Gut. 2018 Oct 20. pii: gutjnl-2018-317543. doi: 10.1136/gutjnl-2018-317543. [Epub ahead of print] No abstract available.

PMID:
30343271
13.

A novel scavenging tool for cancer biomarker discovery based on the blood-circulating nanoparticle protein corona.

Hadjidemetriou M, Al-Ahmady Z, Buggio M, Swift J, Kostarelos K.

Biomaterials. 2018 Oct 13;188:118-129. doi: 10.1016/j.biomaterials.2018.10.011. [Epub ahead of print]

PMID:
30343255
14.

Efflux inhibition by H2S confers sensitivity to doxorubicin-induced cell death in liver cancer cells.

Stokes E, Shuang T, Zhang Y, Pei Y, Fu M, Guo B, Parissenti A, Wu L, Wang R, Yang G.

Life Sci. 2018 Oct 18. pii: S0024-3205(18)30656-8. doi: 10.1016/j.lfs.2018.10.031. [Epub ahead of print]

PMID:
30343125
15.

Hybrid oncocytic/chromophobe renal cell tumor: An integrated genetic and epigenetic characterization of a case.

Pires-Luis A, Montezuma D, Vieira J, Ramalho-Carvalho J, Santos C, Teixeira M, Jerónimo C, Henrique R.

Exp Mol Pathol. 2018 Oct 18. pii: S0014-4800(18)30154-0. doi: 10.1016/j.yexmp.2018.10.008. [Epub ahead of print]

PMID:
30343009
16.

Antidiabetic activities of chloroform fraction of Anthocleista vogelii Planch root bark in rats with diet- and alloxan-induced obesity-diabetes.

Anyanwu GO, Iqbal J, Khan SU, Zaib S, Rauf K, Onyeneke CE, Ojo OO, Nisar-Ur-Rahman.

J Ethnopharmacol. 2018 Oct 18. pii: S0378-8741(18)31806-3. doi: 10.1016/j.jep.2018.10.021. [Epub ahead of print]

PMID:
30342966
17.

Pathogenesis of and New Therapies for Hepatitis D.

Koh C, Heller T, Glenn JS.

Gastroenterology. 2018 Oct 18. pii: S0016-5085(18)35162-X. doi: 10.1053/j.gastro.2018.09.058. [Epub ahead of print]

PMID:
30342879
18.

Risk score system for the prediction of hepatocellular carcinoma in patients with type 2 diabetes: Taiwan Diabetes Study.

Li TC, Li CI, Liu CS, Lin WY, Lin CH, Yang SY, Lin CC.

Semin Oncol. 2018 Oct 17. pii: S0093-7754(17)30162-8. doi: 10.1053/j.seminoncol.2018.07.006. [Epub ahead of print] Review.

PMID:
30342872
19.

HANR promotes hepatocellular carcinoma progression via miR-214/EZH2/TGF-β axis.

Shi Y, Yang X, Xue X, Sun D, Cai P, Song Q, Zhang B, Qin L.

Biochem Biophys Res Commun. 2018 Oct 17. pii: S0006-291X(18)32184-3. doi: 10.1016/j.bbrc.2018.10.038. [Epub ahead of print]

PMID:
30342849
20.

Metformin Associated With Improved Outcomes in Diabetic Patients With Laryngeal and Oropharyngeal Carcinoma.

Ogunsakin A, Infield J, Zuber J, Solomon SS.

Am J Med Sci. 2018 Sep 13. pii: S0002-9629(18)30349-5. doi: 10.1016/j.amjms.2018.09.002. [Epub ahead of print] No abstract available.

PMID:
30342717

Supplemental Content

Loading ...
Support Center